During the past decade, Dialysepraxis Drs. Riedasch/Schreiber conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dialysepraxis Drs. Riedasch/Schreiber" #1 collaborator was "Hexal AG" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dialysepraxis Drs. Riedasch/Schreiber" are "Anemia" (2 trials), "Chronic Kidney Disease" (1 trials) and "Chronic Renal Insufficiency" (1 trials). Many other conditions were trialed in "Dialysepraxis Drs. Riedasch/Schreiber" in a lesser frequency.

Most popular intervention types in "Dialysepraxis Drs. Riedasch/Schreiber" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "HX575 recombinant human erythropoietin alfa" (2 trials), "ERYPO" (1 trials), "ERYPO®, Janssen-Cilag" (1 trials) and "HX575 epoetin alfa Hexal AG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dialysepraxis Drs. Riedasch/Schreiber" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dialysepraxis Drs. Riedasch/Schreiber". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dialysepraxis Drs. Riedasch/Schreiber, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dialysepraxis Drs. Riedasch/Schreiber, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".